New research has provided insight into the functional potential of wool-derived protein, with an initial trial revealing it can influence how the body responds to insulin.
School of Sport, Exercise and Nutrition Professor David Rowlands has been engaging in this research in collaboration with Professor George Dias and Professor Margreet Vissers from the University of Otago as part of a Ministry of Business, Innovation and Employment’s Smart Ideas grant.
As part of the grant in 2015, Professor Rowlands developed an hypothesis building upon research and trials conducted by Professor Dias. Given the the unique amino acid composition of keratin, Professor Rowlands says he suspected it could be used to increase insulin sensitivity in people with diabetes.
“It was an out there idea, but we wanted to trial edible keratin protein derived from sheep’s wool which is particularly rich in cysteine, glycine and arginine which are important for insulin function. As humans, we don’t have natural keratinase enzymes in our gastrointestinal tract, so we had to find a way to make the keratin digestible to unlock its potential.”
Prior to beginning the process, the wool is washed several times before undergoing a novel method using what is essentially a high-pressure microwave oven to break down the sulphur double bonds that tightly bind the keratin together. This unwinds the protein to allow it to be reduced into smaller fragments and make it digestible.
To investigate the effects of the edible keratin protein, 35 participants with type 2 diabetes engaged in a 14-week trial. They consumed 17 grams of keratin blended with whey protein daily, via muffins and capsules, and took part in a standardised exercise programme.
The pilot clinical trial specifically focused on the peripheral tissues of the skeletal muscle, as those with type 2 diabetes often face challenges of being unable to respond effectively to insulin.
Professor Rowlands says the combination of keratin supplementation and exercise across the 14-week period led to a substantial improvement in glucose delivery from the bloodstream into muscle tissues.
“Muscles are where most of the glucose ends up in the body, entering via the bloodstream through glucose transporters. Insulin facilitates glucose intake by increasing the number of glucose transporter proteins, GLUT4, in the cell membrane, allowing more glucose to enter. Our results, measured from the participants’ muscle biopsies, demonstrated an improved GLUT4 response to insulin, enhanced insulin-stimulated microvascular blood flow and increased muscle sensitivity to insulin.”
“The keratin protein contains high levels of cystine and glycine, two of the three precursors needed for production of the antioxidant glutathione. This antioxidant is vital for protecting cells from oxidative stress. While further research is needed, our study indicated an increase in insulin-sensitive glutathione-system associated redox signalling. This suggests that over the course of the trial, there was a shift in the body’s redox environment balance, improving cellular response to insulin. This helps with blood sugar control and may promote a healthier internal environment, with less stress on muscle tissues,” Professor Rowlands says.
While there is more work to come before the keratin protein can become a pantry staple, Professor Rowlands says it could make a difference in the health of people with type 2 diabetes.
“With the keratin protein encouraging enhanced insulin sensitivity, it could improve blood sugar control, reducing the risk of hyperglycaemia, as well as improving energy regulation and production and potentially a reduced medication dependency for a better quality of life.”
“As it currently stands, the wool-derived keratin protein is still a prototype food product, so we’re trying to improve it. We’re not quite there yet, but if we can continue driving it forward, there’s good potential.”
Research paper:
Peeters, W. M., Gram, M., Dias, G. J., Vissers, M. C. M., Hampton, M. B., Dickerhof, N., Bekhit, A. E., Black, M. J., Oxbøll, J., Bayer, S., Dickens, M., Vitzel, K., Sheard, P. W., Danielson, K. M., Hodges, L. D., Brønd, J. C., Bond, J., Perry, B. G., Stoner, L., Cornwall, J., & Rowlands, D. S. (2023). Changes to insulin sensitivity in glucose clearance systems and redox following dietary supplementation with a novel cysteine-rich protein: A pilot randomized controlled trial in humans with type-2 diabetes. Redox Biology, 67, 102918. https://doi.org/10.1016/j.redox.2023.102918
